DocGo Inc. (DCGO) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $9.89K; Additional Paid in CapitalUSD $331.26M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.17M; Retained Earnings (Accumulated Deficit)USD $-214.39M.
- 2026-03-31: Common Stock, Value, IssuedUSD $9.88K; Additional Paid in CapitalUSD $328.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.25M; Retained Earnings (Accumulated Deficit)USD $-198.56M.
- 2025-12-31: Common Stock, Value, IssuedUSD $9.86K; Additional Paid in CapitalUSD $325.42M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.39M; Retained Earnings (Accumulated Deficit)USD $-183.80M.
- 2025-09-30: Common Stock, Value, IssuedUSD $9.78K; Additional Paid in CapitalUSD $317.82M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.43M; Retained Earnings (Accumulated Deficit)USD $-49.73M.
DocGo Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Other USD | Treasury Stock, Shares, Acquired shares | Partners' Capital Account, Public Sale of Units Net of Offering Costs USD | Noncontrolling Interest in Variable Interest Entity USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.89K | $331.26M | $2.17M | $-214.39M | $119.05M | $95.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $9.88K | $328.62M | $2.25M | $-198.56M | $132.31M | $111.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $9.86K | $325.42M | $2.39M | $-183.80M | $144.01M | $125.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $9.78K | $317.82M | $2.43M | $-49.73M | $270.53M | $260.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $9.78K | $316.51M | $2.72M | $-21.96M | $297.28M | $287.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $10.02K | $318.42M | $1.72M | $-10.81M | $309.34M | $301.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $10.19K | $321.09M | $1.22M | $-1.40M | $320.92M | $315.18M | 12 month · $13.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $10.20K | $321.03M | $2.31M | $1.86M | $325.21M | $324.90M | 3 month · $2.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $10.17K | $317.40M | $1.38M | $-3.64M | $315.16M | $317.99M | 3 month · $2.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $10.30K | $320.14M | $1.34M | $-10.17M | $311.32M | $315.08M | 3 month · $4.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $10.41K | $320.69M | $1.48M | $-21.39M | $300.79M | $305.17M | 12 month · $20.40M | (m) | (m) | (m) | (m) | (m) | 12 month · 0.00 | (m) | (m) |
| 2023-09-30 | $10.39K | $315.75M | $808.17K | $-28.96M | $287.60M | $291.55M | 3 month · $3.34M | (m) | (m) | (m) | (m) | (m) | 9 month · 0.00 | (m) | (m) |
| 2023-06-30 | $10.38K | $312.10M | $1.39M | $-33.73M | $279.77M | $283.86M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 0.00 6 month · 0.00 | (m) | (m) |
| 2023-03-31 | $10.29K | $310.05M | $984.86K | $-32.37M | $278.68M | $283.92M | 3 month · $8.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.24M |
| 2022-12-31 | $10.24K | $301.45M | $741.21K | $-28.97M | $273.23M | $278.93M | 12 month · $7.18M | 12 month · $2.06M | (m) | 3 month · $3.73M | (m) | (m) | 3 month · 536.84K | (m) | $5.70M |
| 2022-09-30 | $10.78K | $301.52M | $-276.21K | $-37.04M | $264.22M | $270.83M | 3 month · $1.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $10.56K | $287.30M | $-27.93K | $-40.19M | $247.09M | $254.39M | 3 month · $2.00M | (m) | (m) | 3 month · $3.73M | (m) | (m) | 3 month · 536.84K | (m) | (m) |
| 2022-03-31 | $10.21K | $284.94M | $-38.36K | $-52.93M | $231.98M | $240.26M | 3 month · $1.42M | 3 month · $2.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $10.01K | $283.16M | $-32.50K | $-63.56M | $219.58M | $227.06M | 12 month · $1.38M | 12 month · $333.02K | (m) | (m) | 12 month · $9.57M | (m) | (m) | (m) | $7.48M |
| 2021-09-30 | $288.00 | (m) | (m) | $-12.67M | $-12.67M | $67.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $182.00 | (m) | (m) | $-5.28M | $-13.21M | $66.25M | (m) | (m) | $10.28M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $152.00 | (m) | (m) | $-2.23M | $-10.17M | $65.69M | (m) | (m) | $7.23M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $172.00 | $142.35M | $-48.54K | $-87.30M | $55.00M | $66.95M | (m) | (m) | $9.22M | (m) | (m) | 5 month · $5.20M | (m) | 5 month · $6.79M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $-2.06K | $22.93K | (m) | (m) | (m) | $24.67K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $79.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |